AQP4 and neuromyelitis optica: However, screening for NMO-IgG/AQP4-antibody by tissue-based assays is still recommended as it is cheap and can demonstrate different or new antibodies associated with NMO disease spectrum, while the CBA only demonstrates the antigen of interest overexpressed in the cells.